Ardelyx Inc
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on… Read more
Ardelyx Inc (ARDX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.002x
Based on the latest financial reports, Ardelyx Inc (ARDX) has a cash flow conversion efficiency ratio of 0.002x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($365.00K) by net assets ($154.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ardelyx Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Ardelyx Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ardelyx Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ardelyx Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OXFORD INSTR. PLC LS-05
F:OX3
|
N/A |
|
Anhui Kouzi Distillery Co Ltd
SHG:603589
|
-0.001x |
|
Zhuhai Orbita Control Eng
SHE:300053
|
0.011x |
|
SNKCF
PINK:SNKCF
|
N/A |
|
ABC-MART
F:5B8
|
N/A |
|
Empresa Distribuidora y Comercializadora Norte Sociedad Anónima
F:PWD1
|
0.014x |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
0.009x |
|
Linamar Corporation
PINK:LIMAF
|
0.065x |
Annual Cash Flow Conversion Efficiency for Ardelyx Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Ardelyx Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $173.29 Million | $-44.81 Million | -0.259x | +51.92% |
| 2023-12-31 | $166.82 Million | $-89.72 Million | -0.538x | +24.50% |
| 2022-12-31 | $98.33 Million | $-70.04 Million | -0.712x | +61.42% |
| 2021-12-31 | $82.62 Million | $-152.55 Million | -1.846x | -185.95% |
| 2020-12-31 | $126.11 Million | $-81.44 Million | -0.646x | -57.59% |
| 2019-12-31 | $186.66 Million | $-76.48 Million | -0.410x | +32.47% |
| 2018-12-31 | $115.81 Million | $-70.27 Million | -0.607x | -29.67% |
| 2017-12-31 | $139.31 Million | $-65.19 Million | -0.468x | +2.32% |
| 2016-12-31 | $193.15 Million | $-92.53 Million | -0.479x | +27.38% |
| 2015-12-31 | $108.90 Million | $-71.84 Million | -0.660x | -398.80% |
| 2014-12-31 | $60.68 Million | $13.40 Million | 0.221x | +189.28% |
| 2013-12-31 | $-7.32 Million | $1.81 Million | -0.247x | +98.61% |
| 2012-12-31 | $-1.24 Million | $21.98 Million | -17.769x | -- |